The CD47 therapeutics market is gaining significant traction due to its potential to revolutionize cancer treatment and other medical conditions through novel immune-modulating approaches. CD47, often referred to as the "don't eat me" signal, is a cell surface protein that plays a crucial role in evading immune surveillance by signaling macrophages not to phagocytize cells. This article...